Bristol-Myers Squibb Co (BMY)
51.59
-0.75
(-1.43%)
USD |
NYSE |
Mar 18, 16:00
51.95
+0.36
(+0.70%)
After-Hours: 20:00
Bristol-Myers Squibb Debt to Equity Ratio: 1.351 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 1.351 |
September 30, 2023 | 1.297 |
June 30, 2023 | 1.178 |
March 31, 2023 | 1.189 |
December 31, 2022 | 1.266 |
September 30, 2022 | 1.197 |
June 30, 2022 | 1.290 |
March 31, 2022 | 1.424 |
December 31, 2021 | 1.239 |
September 30, 2021 | 1.202 |
June 30, 2021 | 1.227 |
March 31, 2021 | 1.231 |
December 31, 2020 | 1.340 |
September 30, 2020 | 0.8961 |
June 30, 2020 | 0.9507 |
March 31, 2020 | 0.9358 |
December 31, 2019 | 0.9057 |
September 30, 2019 | 1.414 |
June 30, 2019 | 1.556 |
March 31, 2019 | 0.3953 |
December 31, 2018 | 0.5238 |
September 30, 2018 | 0.5357 |
June 30, 2018 | 0.5997 |
March 31, 2018 | 0.6019 |
December 31, 2017 | 0.6781 |
Date | Value |
---|---|
September 30, 2017 | 0.5711 |
June 30, 2017 | 0.559 |
March 31, 2017 | 0.585 |
December 31, 2016 | 0.4147 |
September 30, 2016 | 0.4372 |
June 30, 2016 | 0.4515 |
March 31, 2016 | 0.4657 |
December 31, 2015 | 0.4689 |
September 30, 2015 | 0.4824 |
June 30, 2015 | 0.4873 |
March 31, 2015 | 0.4797 |
December 31, 2014 | 0.5273 |
September 30, 2014 | 0.5064 |
June 30, 2014 | 0.5048 |
March 31, 2014 | 0.4943 |
December 31, 2013 | 0.5503 |
September 30, 2013 | 0.4897 |
June 30, 2013 | 0.5014 |
March 31, 2013 | 0.5779 |
December 31, 2012 | 0.5428 |
September 30, 2012 | 0.5294 |
June 30, 2012 | 0.3382 |
March 31, 2012 | 0.3315 |
December 31, 2011 | 0.3441 |
September 30, 2011 | 0.3391 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3953
Minimum
Mar 2019
1.556
Maximum
Jun 2019
1.174
Average
1.229
Median
Debt to Equity Ratio Benchmarks
Amgen Inc | 10.37 |
Gilead Sciences Inc | 1.094 |
Johnson & Johnson | 0.4265 |
Eli Lilly and Co | 2.342 |
Karuna Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 95.16B |
Total Liabilities (Quarterly) | 65.67B |
Shareholders Equity (Quarterly) | 29.43B |
Current Ratio | 1.427 |
Net Debt Paydown Yield | -0.13% |